Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)

China flag China · Delayed Price · Currency is CNY
14.86
+0.05 (0.34%)
Feb 4, 2026, 3:04 PM CST
79.25%
Market Cap4.28B +86.1%
Revenue (ttm)797.25M +1.1%
Net Income25.41M +715.6%
EPS0.09 +724.8%
Shares Out289.15M
PE Ratio169.83
Forward PEn/a
Dividend0.10 (0.68%)
Ex-Dividend DateJul 9, 2025
Volume4,846,900
Average Volume9,613,141
Open14.89
Previous Close14.81
Day's Range14.73 - 14.96
52-Week Range8.06 - 32.14
Beta0.67
RSI38.06
Earnings DateApr 17, 2026

About SHE:002365

Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces ethylene oxide, polycarboxylic acid-based water reducer monomers, water reducers, and health products. The company engages in scientific research and technical service, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmaceutical Co., Ltd. was founded in 2001 and is based in Qianjiang, China. [Read more]

Sector Healthcare
Founded 2001
Employees 930
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002365
Full Company Profile

Financial Performance

Financial Statements